NRA-ANASTROZOLE DIN 02565358
Health Canada record
| Active ingredient(s) | ANASTROZOLE 1 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L02BG03 ANASTROZOLE |
| Original market date | |
| Current status date | 30-Jan-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Nora Pharma Inc — licence 3-002506, currently licensed, last inspection rating C (2022-11-29).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ANASTROZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02351218 | ACH-ANASTROZOLE | ACCORD HEALTHCARE INC | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02553686 | AG-ANASTROZOLE TABLETS | ANGITA PHARMA INC. | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02529904 | ANASTROZOLE | SIVEM PHARMACEUTICALS ULC | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02442736 | ANASTROZOLE | SANIS HEALTH INC | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02374420 | APO-ANASTROZOLE | APOTEX INC | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02224135 | ARIMIDEX | ASTRAZENECA CANADA INC | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02392488 | BIO-ANASTROZOLE | BIOMED PHARMA | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02326094 | IPG-ANASTROZOLE | MARCAN PHARMACEUTICALS INC | Tablet | ANASTROZOLE 1 MG | Approved |
| 02540584 | JAMP ANASTROZOLE TABLETS | JAMP PHARMA CORPORATION | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02339080 | JAMP-ANASTROZOLE | JAMP PHARMA CORPORATION | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02379562 | MAR-ANASTROZOLE | MARCAN PHARMACEUTICALS INC | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02393573 | MINT-ANASTROZOLE | MINT PHARMACEUTICALS INC | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02417855 | NAT-ANASTROZOLE | NATCO PHARMA (CANADA) INC | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02320738 | PMS-ANASTROZOLE | PHARMASCIENCE INC | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02395649 | PRO-ANASTROZOLE | PRO DOC LIMITEE | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02392259 | RIVA-ANASTROZOLE | LABORATOIRE RIVA INC. | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02338467 | SANDOZ ANASTROZOLE | SANDOZ CANADA INCORPORATED | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02365650 | TARO-ANASTROZOLE | TARO PHARMACEUTICALS INC | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02394898 | TEVA-ANASTROZOLE | TEVA CANADA LIMITED | Tablet | ANASTROZOLE 1 MG | Marketed |
| 02397692 | ACCEL-ANASTROZOLE TABLETS | ACCEL PHARMA INC | Tablet | ANASTROZOLE 1 MG | Cancelled Pre Market |
| 02534118 | AG-ANASTROZOLE | ANGITA PHARMA INC. | Tablet | ANASTROZOLE 1 MG | Dormant |
| 02404990 | AURO-ANASTROZOLE | AURO PHARMA INC | Tablet | ANASTROZOLE 1 MG | Cancelled Post Market |
| 02458799 | CCP-ANASTROZOLE | CELLCHEM PHARMACEUTICALS INC. | Tablet | ANASTROZOLE 1 MG | Cancelled Post Market |
| 02459191 | DOM-ANASTROZOLE | DOMINION PHARMACAL | Tablet | ANASTROZOLE 1 MG | Cancelled Pre Market |
| 02379104 | MED-ANASTROZOLE | GENERIC MEDICAL PARTNERS INC | Tablet | ANASTROZOLE 1 MG | Dormant |
| 02361418 | MYLAN-ANASTROZOLE | MYLAN PHARMACEUTICALS ULC | Tablet | ANASTROZOLE 1 MG | Cancelled Post Market |
| 02328690 | RAN-ANASTROZOLE | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | ANASTROZOLE 1 MG | Cancelled Post Market |
| 02313049 | TEVA-ANASTROZOLE | TEVA CANADA LIMITED | Tablet | ANASTROZOLE 1 MG | Cancelled Post Market |
| 02427818 | VAN-ANASTROZOLE | VANC PHARMACEUTICALS INC | Tablet | ANASTROZOLE 1 MG | Cancelled Post Market |
| 02326035 | ZINDA-ANASTROZOLE | STASON PHARMACEUTICALS INC | Tablet | ANASTROZOLE 1 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36805 | 2026-01-30 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement between two manufacturers |
International API supply for ANASTROZOLE
7 valid EDQM Certificates of Suitability from 7 holders. 14 active FDA Drug Master Files.
Request a quote for NRA-ANASTROZOLE